NCT02225379View on ClinicalTrials.gov

Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of Hypoglycemia

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Type 1 DiabetesNocturnal Hypoglycemia
Interventions
DEVICE

Hypo-Sense (non invasive sensor)

Parallel measurements of capillary blood glucose using reference methods (both capillary glucometer and continuous sensor) and data generated by the non- invasive study device during approximately 4 hours, in which a hypoglycemic event will be induced.

Trial Locations (1)

49202

Schneider Children's Medical Center, Petah Tikva

All Listed Sponsors
collaborator

Night Sense Ltd

UNKNOWN

lead

Rabin Medical Center

OTHER

NCT02225379 - Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of Hypoglycemia | Biotech Hunter | Biotech Hunter